Candel Therapeutics Inc (CADL)

8.80 +0.17 (+1.97%) USD  |  NASDAQ  |  Dec 24, 16:00
More

Candel Therapeutics Research and Development Expense (Quarterly): 5.416M for Sept. 30, 2024

Research and Development Expense (Quarterly) Chart

View Research and Development Expense (Quarterly) for CADL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Quarterly) Range, Past 5 Years

View Research and Development Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Quarterly) Benchmarks

View Research and Development Expense (Quarterly) Benchmarks
Start Trial
Pfizer Inc 2.598B
AnaptysBio Inc 42.21M
Bristol-Myers Squibb Co 2.374B
Inovio Pharmaceuticals Inc 18.73M
NovaBay Pharmaceuticals Inc 0.004M